AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FT. MYERS, FLA. -- Proteomic analysis of cerebrospinal fluid is useful for identifying biomarkers of severe preeclampsia, a study suggests.
The technology could help identify candidates for treatment, Dr. Errol R. Norwitz of Yale-New Haven Hospital reported at the annual meeting of the Society for Obstetric Anesthesia and Perinatology.
For the study, cerebrospinal fluid was obtained at the time of spinal anesthesia from seven patients with severe preeclampsia, eight patients with mild preeclampsia, and seven negative controls. A preeclampsia proteomic biomarker score was assigned to each specimen. Individual specimens were analyzed in blinded fashion, and scores were compared.
The proteomic biomarker score distinguished severe preeclampsia from mild preeclampsia and controls with 85.7% sensitivity and 100% ...
Source: HighBeam Research, Identifies candidates for treatment: CSF analysis yields clues to...